2024 年业绩符合我们预期公司公布2024 年业绩:收入167.47 亿美元,同比+17.6%;核心净利润37.25 亿美元,同比+24.2%;核心EPS 2.51 美元,2023 年为2.05 美元。4 季度和全年业绩超出此前(3Q24 业绩会)管理层指引,但符合我们的预期。发展趋势电生理板块高歌猛进。2024 全年,电生理收入19.04 亿美元,同比增长138%;其中美国地区收入12.56 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.